Associated Papers
Voltage-gated potassium channels as a potential therapeutic target for the treatment of neurological and psychiatric disorders.
Faulkner IE et al.
Frontiers in Cellular Neuroscience, 2024
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
Ambrosino P et al.
Epilepsia, 2023
A KCNC1-related neurological disorder due to gain of Kv3.1 function.
Clatot J et al.
Annals of Clinical and Translational Neurology, 2023
Select a paper to view details